Pyelonephritis

Renal Pathology
http://www.dent.ohio-state.edu/courses/path655/Path%20655%20Renal%20II.comp.ppt

Case Study
Tania Guevara, Anthony Edmund
http://instructional1.calstatela.edu/nmcquee/Micro302/Group%20cases/Case%201.PPT

Urinary System
http://instructional1.calstatela.edu/kkholle/384N/13)%20Urinary%20System.ppt

Urinary tract infection in children
Professor Abdelaziz Elamin
http://www.pitt.edu/~super7/43011-44001/43861.ppt

Introduction to Clinical Laboratory Practices Renal Diseases
http://colleges.weber.edu/chp/cls/clsonline/1113/Renal%20Disease.ppt

Urinary Tract Infection
Michele Ritter, M.D.
http://www9.georgetown.edu/faculty/wheltosa/Shelly_UTI.ppt

Infections of the Urinary Tract
Denise Schain MD
http://www.mgm.ufl.edu/~gulig/mmid/lectures/UTI_MMID_2011_rev.ppt

Acute Pyelonephritis
RenalPathology-Labs3,4,5.ppt

Radical Nephrectomy
PATHOLOGY-ANSWER.ppt

Diseases of the Urinary System
Diseases of the Urinary System.ppt

Chronic renal failure
Stephen P. DiBartola, DVM
Chronic renal failure.ppt

Fever During and After Childbirth
Fever During and After Childbirth.ppt

Laboratory Evaluation of Urinary Tract Infection
Dr. John R. Warren
Laboratory_Evaluation_of_Urinary_Tract_Infection_v1-_3.ppt

Staphylococcus and Micrococcus
Dr. John R. Warren
Staphylococcus_and_Micrococcus_v1-_3____.ppt

Pediatric urinary tract infection
Scott Weissman, MD
Pediatric urinary tract infection.ppt

Preterm labor
Joseph Breuner, MD
Preterm labor.ppt

Meningitis and UTI
emergency_lecture_series/Meningitis and UTI.PPT

Complement Inhibition for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Monica Bessler, MD, PhD
Complement Inhibition.ppt

UTI
Lindsay Chase MD
UTIppt

Top Ten Rules of a CPC
Clinical Pathology Conference
Lisa L. Willett, MD
Top Ten Rules of a CPC.ppt

Pediatric Urinary Tract Infections
Eddie Needham, MD, FAAFP
Pediatric Urinary Tract Infections.ppt

Empiric Treatment: Pneumonia
Empiric Treatment: Pneumonia.ppt

Urinary Disorders
Infectious Urinary Disorders
Urinary Disorders.ppt

Diseases of the Urinary and Reproductive System
Diseases of the Urinary and Reproductive System.ppt

600 Published free text articles

1. Incidental primary papillary mucinous adenocarcinoma of the renal pelvis in a case of non-functioning kidney due to chronic pyelonephritis and pelvic calculus.
2. Clinical profile and outcome of conservatively managed emphysematous pyelonephritis.
3. Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in korean adults: a randomized, double-blind, multicenter trial.
4. Xanthogranulomatous pyelonephritis: A rare entity.
5. Conservative management of emphysematous pyelonephritis.
6. Clinical characteristics and risk factors for septic shock in patients receiving emergency drainage for acute pyelonephritis with upper urinary tract calculi.
7. Acute bilateral renal vein thrombosis secondary to sepsis from pyelonephritis.
8. Risk factors of renal scars in children with acute pyelonephritis.
9. Xanthogranulomatous pyelonephritis presenting with thrombocytopenia and renal mass.
10. Computed tomography findings in xanthogranulomatous pyelonephritis.
11. Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis.
12. Laparoscopic versus open nephrectomy for xanthogranulomatous pyelonephritis: An outcome analysis.
13. Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.
14. The clinical and imaging presentation of acute "non complicated" pyelonephritis: a new profile for an ancient disease.
15. Simple nephrectomy in a young woman for recurrent pyelonephritis utilizing laparoendoscopic single-site surgery (LESS).
16. Emphysematous pyelonephritis with complete duplication of the left urinary tract.
17. Emphysematous pyelonephritis concurrent with psoas muscle abscess.
18. Acute pyelonephritis and renal abscesses in adults--correlating clinical parameters with radiological (computer tomography) severity.
19. Doppler ultrasonography as a predictive tool for permanent kidney damage following acute pyelonephritis: comparison with dimercaptosuccinic acid scintigraphy.
20. Renal collision tumor in association with xanthogranulomatous pyelonephritis.
21. Recovery of a catalase-negative Staphylococcus epidermidis strain in blood and urine cultures from a patient with pyelonephritis.
22. Role of vitamin A in preventing renal scarring after acute pyelonephritis.
23. Discordant findings on dimercaptosuccinic acid scintigraphy in children with multi-detector row computed tomography-proven acute pyelonephritis.
24. Acute pyelonephritis and renal scarring are caused by dysfunctional innate immunity in mCxcr2 heterozygous mice.
25. Xanthogranulomatous pyelonephritis: a retrospective review of 16 cases.
26. Renal replacement lipomatosis with coexisting xanthogranulomatous pyelonephritis in a pregnant woman.
27. Renal replacement lipomatosis and xanthogranulomatous pyelonephritis: differential diagnosis.
28. Nephrobronchial fistula complicating neglected nephrolithiasis and xanthogranulomatous pyelonephritis.
29. Five patients with emphysematous pyelonephritis.
30. The influence of chronic renal failure on the spectrum and antimicrobial susceptibility of uropathogens in community-acquired acute pyelonephritis presenting as a positive urine culture.
31. Are oral antibiotics equivalent to intravenous antibiotics for the initial management of pyelonephritis in children?
32. Comparison of virulence variations on MDCK monolayers by Escherichia coli isolated from acute lobar nephronia and acute pyelonephritis.
33. Emphysematous pyelonephritis and pneumo-vena cava.
34. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.
35. RE: A guideline for the inpatient care of children with pyelonephritis.
36. Evaluation of Effectiveness of Vitamins C and E on Prevention of Renal Scar due to Pyelonephritis in Rat.
37. Gas in the renal area: emphysematous pyelonephritis.
38. Liesegang rings in xanthogranulomatous pyelonephritis: a case report.
39. Rare coexistence of keratinizing squamous cell carcinoma with xanthogranulomatous pyelonephritis in the same kidney: report of two cases.
40. Diagnostic and treatment difficulties of pyelonephritis in pregnancy in resource-limited settings.
41. Retroperitoneal-necrotizing fasciitis due to chronic pyelonephritis.
42. [A case of infiltrating transitional cell carcinoma of kidney difficult to distinguish from xanthogranulomatous pyelonephritis].
43. Emphysematous pyelonephritis.
44. Fulminant emphysematous pyelonephritis (EPN) in a diabetic patient suspected of having multiple tumors.
45. Emphysematous and xanthogranulomatous pyelonephritis: rare diagnosis.
46. Technetium Tc 99m dimercaptosuccinic acid renal scintigraphy in children with acute pyelonephritis: correlation with other imaging tests.
47. Primary adenocarcinoma of ureter mimicking pyelonephritis.
48. Evaluation of tumour necrosis factor-alpha and interleukin-1beta in an experimental pyelonephritis model induced with planktonic and biofilms cells of Pseudomonas aeruginosa.
49. A guideline for the inpatient care of children with pyelonephritis.
50. Pyelonephritis in slaughter pigs and sows: morphological characterization and aspects of pathogenesis and aetiology.
51. Sonographic diagnosis of emphysematous pyelonephritis in a clinically stable patient.
52. Xanthogranulomatous Pyelonephritis in a male child with renal vein thrombus extending into the inferior vena cava: a Case Report.
53. Amyloidosis secondary to xanthogranulomatous pyelonephritis: a rare association.
54. Xanthogranulomatous pyelonephritis in childhood: diagnosis difficulties and success of conservative treatment.
55. Imaging of emphysematous pyelonephritis: self-assessment module.
56. Subcutaneous emphysema as a clinical finding in emphysematous pyelonephritis.
57. The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients.
58. Diagnosing Acute Pyelonephritis with CT, Tc-DMSA SPECT, and Doppler Ultrasound: A Comparative Study.
59. Xanthogranulomatous pyelonephritis in a horse-shoe kidney.
60. Scrotum balloon: an unusual presentation of emphysematous pyelonephritis.
61. Fragment Bb: evidence for activation of the alternative pathway of the complement system in pregnant women with acute pyelonephritis.
62. A patient with an unusual cause right lower quadrant pain and vomiting: pyelonephritis of an ectopic right kidney masquerading as acute appendicitis.
63. Maternal plasma retinol binding protein 4 in acute pyelonephritis during pregnancy.
64. [Emphysematous pyelonephritis and radical nephrectomy in hepatorenal polycystosis].
65. Emphysematous pyelonephritis.
66. Severe renal failure in acute bacterial pyelonephritis: do not forget corticosteroids.
67. Emphysematous pyelonephritis, ureteritis and cystitis in a diabetic patient.
68. Emphysematous pyelonephritis in a renal transplant patient.
69. Cystitis, pyelonephritis, and urolithiasis in rats accidentally fed a diet deficient in vitamin A.
70. Chronic pyelonephritis presenting as a renal sinus tumor with retroperitoneal extension: a case report.
71. A case of fatal emphysematous pyelonephritis presenting as lower limb gaseous gangrene.
72. [Pregnant patient with acute pyelonephritis and renal corticomedullary abscess: ultrasound and MRI imaging].
73. Laparoscopic heminephrectomy in a horseshoe kidney affected by xanthogranulomatous pyelonephritis.
74. Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritis.
75. Emphysematous pyelonephritis - case report and evaluation of radiological features.
76. [Emphysematous pyelonephritis. Case report].
77. [Xanthogranulomatous pyelonephritis: Review of 10 cases].
78. Recurrent pyelonephritis revealing a calcified tuberculoma of the filum terminale.
79. [A case of emphysematous pyelonephritis successfully treated by endotoxin absorption therapy and transurethral retrograde drainage].
80. Recurrent pyelonephritis as a sign of 'sponge kidney'.
81. Low circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection.
82. Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis.
83. [Pyelonephritis in crossed-fused renal ectopia].
84. [Two cases of emphysematous pyelonephritis successfully treated by transurethral catheterization].
85. [Mycotic aneurysm after puerperal sepsis, pyelonephritis and endocarditis].
86. Bilateral emphysematous pyelonephritis cured by antibiotics alone: a case and literature review.
87. Acute pyelonephritis: clinical characteristics and the role of the surgical treatment.
88. [Proteinuria in urinary infection and acute pyelonephritis in paediatric patients: can it replace scintigraphic studies in diagnostic localisation?].
89. Diagnostic potential of urinary tumor necrosis factor-alpha in children with acute pyelonephritis.
90. Urinary interleukin-8 in acute pyelonephritis of children: a before-after study.
91. [Renal collecting duct cells act as modulators of the innate immune response during ascending pyelonephritis].
92. Escherichia coli 0157 enterohaemorrhagic colitis associated with pyelonephritis: CT findings.
93. Treatment of pyelonephritis and risk of renal scarring.
94. Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.
95. A case of emphysematous pyelonephritis.
96. Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis.
97. Surgically discovered xanthogranulomatous pyelonephritis invading inferior vena cava with coexisting renal cell carcinoma.
98. Early antibiotic treatment of pyelonephritis in children is still mandatory.
99. Early antibiotic treatment of pyelonephritis in children is still mandatory.
100. Pneumomediastinum as first manifestation of emphysematous pyelonephritis in a patient who is non-diabetic.
101. A rare association of emphysematous pyelonephritis with unrecognized diabetes and polycystic kidney.
102. [Can plasma procalcitonin levels predict renal scarring in children with acute pyelonephritis?].
103. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial.
104. [Emphysematous pyelonephritis in peritoneal dialysis].
105. 'Bench' MRI before transplant on harvested kidneys: a possible tool for diagnosis of acute pyelonephritis.
106. Emphysematous pyelonephritis with flank rash.
107. Ampicillin resistance and outcome differences in acute antepartum pyelonephritis.
108. Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.
109. Emphysematous pyelonephritis in type II diabetes: A case report of an undiagnosed ureteric colic.
110. Air in the kidney: between emphysematous pyelitis and pyelonephritis.
111. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
112. Finding the path of least antimicrobial resistance in pyelonephritis.
113. [Is oral antibiotic therapy equally effective than parenteral therapy in the first acute pyelonephritis episode in children?].
114. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials.
115. Emphysematous pyelonephritis, a rare cause of pneumoperitoneum: a case report and review of literature.
116. Nephrolithiasis and pyelonephritis in two West Indian manatees (Trichechus manatus spp.).
117. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial.
118. Bacteremia and pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis.
119. [Case of fungal endophthalmitis from pyelonephritis caused by ureterolithiasis].
120. Metachronous emphysematous pyelonephritis and xanthogranulomatous pyelonephritis in the contralateral kidney: an extremely rare condition.
121. Prospective, randomized trial comparing short and long intravenous antibiotic treatment of acute pyelonephritis in children: dimercaptosuccinic acid scintigraphic evaluation at 9 months.
122. The characteristics of acute pyelonephritis in geriatric patients: experiences in rural northeastern Taiwan.
123. Xanthogranulomatous pyelonephritis: a retrospective study of 10 cases and review of the literature.
124. Emphysematous pyelonephritis complicated with extrarenal abscesses.
125. Procalcitonin implication in renal cell apoptosis induced by acute pyelonephritis in children.
126. Pyelonephritis (acute) in non-pregnant women.
127. Urinary N-acetyl-beta-D-glucosaminidase as a diagnostic marker of acute pyelonephritis in children.
128. Preoperative diagnosis of xanthogranulomatous pyelonephritis.
129. Xanthogranulomatous pyelonephritis.
130. Xanthgranulomatous pyelonephritis associated with Staphylococcus aureus.
131. Acute pyelonephritis: management steps that remain unresolved.
132. Successful medical treatment of emphysematous pyelonephritis.
133. [Imaging features of xanthogranulomatous pyelonephritis].
134. [Case no. 4. Pyelonephritis complicated by suppurative thrombosis of the renal vein, with septic pulmonary embolism].
135. Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis.
136. Pyelonephritis associated with Staphylococcus intermedius in a Siberian tiger (Panthera tigris altaica).
137. A genetic basis of susceptibility to acute pyelonephritis.
138. Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy.
139. [The use of renal ultrasound for adult acute pyelonephritis].
140. Xanthogranulomatous like Pyelonephritis with no Xanthoma Cells: Should these Always be Present?
141. Bilateral emphysematous pyelonephritis: a case report.
142. Xanthogranulomatous pyelonephritis in a renal allograft associated with xanthogranulomatous diverticulitis: report of the first case and review of the literature.
143. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial.
144. Emphysematous pyelonephritis with calculus: Management strategies.
145. Antibiotic resistance and pyelonephritis.
146. Population-based epidemiologic analysis of acute pyelonephritis.
147. Chronic pyelonephritis presenting as multiple tumor-like renal lesions.
148. [Emphysematous pyelonephritis with perirenal abscess cured with conservative medical treatment].
149. Failure of sonography to visualize a kidney affected by emphysematous pyelonephritis.
150. Paecilomyces pyelonephritis in a patient with urolithiasis.
151. Bilateral emphysematous pyelonephritis in a patient with no known risk factors.
152. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection.
153. Hafnia alvei endocarditis following pyelonephritis in a permanent pacemaker carrier.
154. Atypical presentation of xanthogranulomatous pyelonephritis: a case report.
155. Emphysematous pyelonephritis.
156. Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coli.
157. [Nephrobronchial fistula secondary to chronic xanthogranulomatous pyelonephritis as a cause of pulmonary abscess and persistent hemoptysis].
158. [Xanthogranulomatous pyelonephritis presenting a subcutaneous mass in the lower abdomen: a case report].
159. MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis.
160. [Acute pyelonephritis in ectopic crossed and fused kidney].
161. Veterinary diagnostic imaging. Retroperitoneal abscess and regional cellulitis secondary to a pyelonephritis within the left kidney.
162. Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways.
163. Emphysematous pyelonephritis treated with percutaneous catheter drainage and antibiotics.
164. Oestroprogestagens and severe acute pyelonephritis: a casual or causal association?
165. DMSA scan in acute pyelonephritis.
166. Emphysematous pyelonephritis.
167. [Renal scars after one year of follow up in children with a first episode of acute pyelonephritis].
168. Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae.
169. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study.
170. Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.
171. An unusual case of dramatic acute bilateral pyelonephritis with systemic bacterial dissemination caused by uropathogenic Escherichia coli.
172. Emphysematous pyelonephritis: a consequence of adenocarcinoma of urinary bladder in a nondiabetic patient.
173. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women.
174. Novel mechanism of P-fimbriated Escherichia coli virulence in pyelonephritis.
175. Emphysematous pyelonephritis caused by Bacteroides fragilis.
176. Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy.
177. Evaluation of the use of DMSA in culture positive UTI and culture negative acute pyelonephritis.
178. Challenges in preventing pyelonephritis in pregnant women in Indigenous communities.
179. [Cholestatic jaundice complicating acute pyelonephritis in a 6-year-old girl].
180. Diagnosis and management of acute pyelonephritis in adults.
181. Nephrobronchial fistula secondary to xantogranulomatous pyelonephritis.
182. Markov Chain modeling of pyelonephritis-associated pili expression in uropathogenic Escherichia coli.
183. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis.
184. Necrotizing fasciitis caused by xanthogranulomatous and emphysematous pyelonephritis: importance of the inferior lumbar triangle pathway.
185. The epidemiology of acute pyelonephritis in South Korea, 1997-1999.
186. [Xanthogranulomatous pyelonephritis: clinical, radiological and pathologic characteristics].
187. Pyelonephritis and urosepsis caused by Streptococcus pneumoniae.
188. Procalcitonin: a marker of severity of acute pyelonephritis among children.
189. Clinics in diagnostic imaging (99). Left emphysematous pyelonephritis.
190. Treatment of acute pyelonephritis in children: conclusions should have been more cautious.
191. Inferior vena cava thrombosis due to acute pyelonephritis.
192. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
193. Quantitative analysis of 99mTc-DMSA during acute pyelonephritis for prediction of long-term renal scarring.
194. Use of administrative healthcare claims to examine the effectiveness of trimethoprim-sulfamethoxazole versus fluoroquinolones in the treatment of community-acquired acute pyelonephritis in women.
195. Treatment of acute pyelonephritis in children.
196. Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis.
197. Evaluation of inflammatory and renal-injury markers in women treated with antibiotics for acute pyelonephritis caused by Escherichia coli.
198. Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa.
199. Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection.
200. A patient with E. coli-induced pyelonephritis and sepsis who transiently exhibited symptoms associated with primary biliary cirrhosis.
201. Primary biliary cirrhosis and E. coli-induced pyelonephritis; are infectious agents related to the pathogenesis of primary biliary cirrhosis?
202. [Renal scintigraphy using technetium dimercaptosuccinic acid in the diagnosis of pyelonephritis in children: study of 17 cases]
203. Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary?
204. Long-term follow-up of women hospitalized for acute pyelonephritis.
205. Antimicrobial-induced endotoxaemia in patients with sepsis in the field of acute pyelonephritis.
206. [Pseudotuberculous pyelonephritis associated with staghorn calculus: a case report].
207. [Once-daily gentamicin dosing versus thrice-daily dosing in infants with acute pyelonephritis].
208. Superior vena cava syndrome due to fibrosing mediastinitis histologically identical to xanthogranulomatous pyelonephritis.
209. Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1beta-deficient mice.
210. Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men.
211. Acute bilateral emphysematous pyelonephritis successfully managed by medical therapy alone: a case report and review of the literature.
212. [Acute pyelonephritis with symptoms compatible with arthritis of the hip].
213. Severe renal hemorrhage caused by pyelonephritis in 7 horses: clinical and ultrasonographic evaluation.
214. Acute graft pyelonephritis and long-term kidney allograft outcome.
215. [Acute pyelonephritis in children with minimal or normal urine findings].
216. Plasma and urinary soluble adhesion molecule expression is increased during first documented acute pyelonephritis.
217. Pyelonephritis caused by multiple clones of Escherichia coli, susceptible and resistant to co-amoxiclav, after a 45 day course of co-amoxiclav.
218. Color and power Doppler sonography versus DMSA scintigraphy in acute pyelonephritis and in prediction of renal scarring.
219. Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial.
220. Renal fibrosis: prediction from acute pyelonephritis focus volume measured at 99mTc dimercaptosuccinic acid SPECT.
221. Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: potential therapeutic impact.
222. Percutaneous conservative management of emphysematous pyelonephritis.
223. Pseudotuberculous pyelonephritis in a patient with autosomal dominant polycystic kidney disease undergoing long-term haemodialysis.
224. Transient renal glycosuria in a patient with acute pyelonephritis.
225. Dr operon-associated invasiveness of Escherichia coli from pregnant patients with pyelonephritis.
226. The osmotic stress response and virulence in pyelonephritis isolates of Escherichia coli: contributions of RpoS, ProP, ProU and other systems.
227. Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin.
228. [Pyelonephritis in children--a retrospective study].
229. Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring.
230. Interleukin-8 receptor deficiency confers susceptibility to acute pyelonephritis.
231. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
232. Acute pyelonephritis: comparison of diagnosis with 99mTc-DMSA, SPECT, spiral CT, MR imaging, and power Doppler US in an experimental pig model.
233. Diuretic MAG3 scintigraphy (F0) in acute pyelonephritis: regional parenchymal dysfunction and comparison with DMSA.
234. Long-term follow-up of patients presenting to adult nephrologists with chronic pyelonephritis and 'normal' renal function.
235. Renal cytokine responses in acute Escherichia coli pyelonephritis in IL-6-deficient mice.
236. Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis.
237. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart.
238. How accurate is dimercaptosuccinic acid scintigraphy for the diagnosis of acute pyelonephritis? A meta-analysis of experimental studies.
239. Emphysematous pyelonephritis: a rare presentation.
240. Massive proteinuria in a patient with chronic pyelonephritis.
241. Images in clinical medicine. Xanthogranulomatous pyelonephritis.
242. Comparative efficacy of gemifloxacin in experimental models of pyelonephritis and wound infection.
243. Predominance of class II papG allele of Escherichia coli in pyelonephritis in infants with normal urinary tract anatomy.
244. [Comparison between scintigraphy, B-mode, and power Doppler sonography in acute pyelonephritis in children].
245. Xanthogranulomatous pyelonephritis presenting as emphysematous pyelonephritis: a rare association.
246. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).
247. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
248. Xanthogranulomatous pyelonephritis in childhood.
249. Experimental gestational pyelonephritis induces preterm births and low birth weights in C3H/HeJ mice.
250. Images in clinical medicine. Emphysematous pyelonephritis.
251. [Emphysematous pyelonephritis: apropos of 4 cases].
252. Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice.
253. Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration.
254. Quantitative 99mTc-DMSA uptake in experimental pyelonephritis.
255. Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis.
256. Emphysematous pyelonephritis in a transplanted kidney: successful percutaneous treatment.
257. Emphysematous pyelonephritis in two diabetic patients with complete uterine prolapse and cystocele.
258. Subcapsular hematoma as a complication of acute pyelonephritis: a case report.
259. Systemic amyloidosis secondary to xantogranulomatous pyelonephritis.
260. [Retrograde cystography after a first episode of acute pyelonephritis in the child and adolescent].
261. Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and Catheter-associated bacteriuria and from fecal samples.
262. Technetium-99m-MAG3 in early identification of pyelonephritis in children.
263. Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice.
264. Recurrent graft pyelonephritis and pneumaturia resulting from a colovesical fistula secondary to silent diverticulitis.
265. A study of interleukin-8 and defensins in urine and plasma of patients with pyelonephritis and glomerulonephritis.
266. Treatment of enterococcal pyelonephritis with trovafloxacin and rifampin: in vitro-in vivo contrast.
267. US case of the day. Emphysematous pyelonephritis.
268. Molecular cloning and characterization of Dr-II, a nonfimbrial adhesin-I-like adhesin isolated from gestational pyelonephritis-associated Escherichia coli that binds to decay-accelerating factor.
269. Scintigraphic detection of pyelonephritis.
270. Re: Emphysematous pyelonephritis producing rapid gas formation.
271. Xanthogranulomatous pyelonephritis.
272. Xanthogranulomatous pyelonephritis caused by Surgical in a renal allograft.
273. Focal xanthogranulomatous pyelonephritis mimicking a renal tumor: CT- and MR-findings and evolution under therapy.
274. Role of type-1 fimbriae in the pathogenesis of chronic pyelonephritis in relation to reactive oxygen species.
275. Xanthogranulomatous pyelonephritis in the native kidney of a renal transplant recipient.
276. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.
277. Assessment of radioisotopic micturating cystography for the diagnosis of vesicoureteric reflux in renal transplant recipients with acute pyelonephritis.
278. Emphysematous pyelonephritis producing rapid gas formation.
279. Tumour necrosis factor soluble receptors I and II and interleukin-1 receptor antagonist in acute pyelonephritis in relation to bacterial virulence-associated traits and renal function.
280. In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains.
281. Emphysematous pyelonephritis or renal abscess?
282. Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci, Escherichia coli, and Pseudomonas aeruginosa in experimental murine pyelonephritis.
283. Technetium-99m-DMSA renal cortical scintigraphy to detect experimental acute pyelonephritis in piglets: comparison of planar (pinhole) and SPECT imaging.
284. Technetium-99m-DMSA renal SPECT in diagnosing and monitoring pediatric acute pyelonephritis.
285. Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992; impact of diabetes, pregnancy, and aboriginal origin.
286. Power Doppler sonographic pattern of acute pyelonephritis in children: comparison with CT.
287. Xanthogranulomatous pyelonephritis: report of nonsurgical management of a case and review of the literature.
288. Randomized clinical trial of antibiotic therapy for antenatal pyelonephritis.
289. An unusual manifestation of xanthogranulomatous pyelonephritis: bilateral focal solid renal masses.
290. Xanthogranulomatous pyelonephritis.
291. Nephrobronchial fistula and lung abscess resulting from nephrolithiasis and pyelonephritis.
292. Sonographic measurement of renal enlargement in children with acute pyelonephritis and time needed for resolution: implications for renal growth assessment.
293. An ascending non-obstructive model for chronic pyelonephritis in BALB/c mice.
294. Emphysematous pyelonephritis: successful treatment with percutaneous drainage.
295. dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor.
296. Yellow nail syndrome and xanthogranulomatous pyelonephritis.
297. Climatic factors and the incidence of pyelonephritis during pregnancy.
298. Clinical trial of the outpatient management of pyelonephritis in pregnancy.
299. The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract.
300. Renal scarring after acute pyelonephritis.
301. Enterococcus faecalis aggravates pyelonephritis caused by Pseudomonas aeruginosa in experimental ascending mixed urinary tract infection in mice.
302. Emphysematous pyelonephritis.
303. [Xanthogranulomatous pyelonephritis].
304. Pyelonephritis in a pronghorn antelope.
305. L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis.
306. Emphysematous pyelonephritis successfully treated with nephrectomy and granulocyte colony-stimulating factor.
307. Unilateral fungal pyelonephritis in a dog.
308. Emphysematous pyelonephritis.
309. Renal scarring after acute pyelonephritis.
310. Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugate.
311. Urethral obstruction of 6 hours or less causes bacteriuria, bacteremia, and pyelonephritis in mice challenged with "nonuropathogenic" Escherichia coli.
312. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.
313. Protective anti-idiotype antibodies in the primate model of pyelonephritis.
314. Asymptomatic acute pyelonephritis as a cause of acute renal failure in the elderly.
315. Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children.
316. Local cytokine production in a murine model of Escherichia coli pyelonephritis.
317. Image interpretation session. Focal xanthogranulomatous pyelonephritis.
318. Attenuation of antibody response to acute pyelonephritis by treatment with antibiotics.
319. Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model.
320. Diagnosis of acute pyelonephritis in children: comparison of sonography and 99mTc-DMSA scintigraphy.
321. From the Archives of the AFIP. Xanthogranulomatous pyelonephritis.
322. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.
323. Xanthogranulomatous pyelonephritis, perinephric type--a case report.
324. Fatal acute pyelonephritis following pulsed methylprednisolone for rheumatoid arthritis.
325. Biochemical and histologic findings in experimental pyelonephritis due to Ureaplasma urealyticum.
326. The effect of parenteral iron administration on the development of Staphylococcus aureus-induced experimental pyelonephritis in rats.
327. Lung abscess secondary to xanthogranulomatous pyelonephritis.
328. Nucleolar organiser regions in kidney tumours and xanthogranulomatous pyelonephritis.
329. Effect of Enterococcus faecalis pyelonephritis on the intracortical accumulation kinetics of gentamicin in rats.
330. Ureteral involvement in stage I xanthogranulomatous pyelonephritis--(a case report).
331. Xanthogranulomatous pyelonephritis--(a clinicopathological study of 15 cases)
332. Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up.
333. Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring.
334. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
335. Bacteriologic and serologic findings in experimental pyelonephritis caused by Ureaplasma urealyticum.
336. [Emphysematous pyelonephritis a case report and review of the literature--comparative study with Japan and other countries].
337. Phase-variation of pyelonephritis-associated pili in Escherichia coli: evidence for transcriptional regulation.
338. Emphysematous pyelonephritis.
339. [Urinary N-acetyl-beta-D-glucosaminidase activity in acute pyelonephritis patients with spinal cord injuries].
340. Renal parenchymal volume during and after acute pyelonephritis measured by ultrasonography.
341. Exacerbation of experimental pyelonephritis by cyclosporin A.
342. Renal pharmacokinetic changes of gentamicin during enterococcal pyelonephritis.
343. Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.
344. Development of fatal bilateral xanthogranulomatous pyelonephritis in a paraplegic patient: case report.
345. Intravenous enoxacin for the treatment of acute pyelonephritis: pharmacokinetic and clinical study.
346. Synthetic peptides corresponding to protective epitopes of Escherichia coli digalactoside-binding pilin prevent infection in a murine pyelonephritis model.
347. Maternal immunization with P fimbriae for the prevention of neonatal pyelonephritis.
348. LY146032, alone and in combination with gentamicin, for the treatment of enterococcal pyelonephritis in the rat model.
349. Serological response to the P fimbriae of uropathogenic Escherichia coli in pyelonephritis.
350. Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.
351. Cellular basis of host defence in pyelonephritis. III. Deletion of individual components.
352. Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model.
353. Xanthogranulomatous pyelonephritis--study of 14 cases.
354. Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis.
355. Cellular basis of host defence in pyelonephritis. II. Acute infection.
356. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
357. Acute renal failure associated with acute pyelonephritis and consumption of non-steroidal anti-inflammatory drugs.
358. Cellular basis of host defence in pyelonephritis. I. Chronic infection.
359. Acute renal failure associated with acute pyelonephritis and consumption of non-steroidal anti-inflammatory drugs.
360. Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis.
361. [A case of bilateral emphysematous pyelonephritis associated with diabetes mellitus].
362. Management of unilateral chronic pyelonephritis.
363. Gal-Gal pyelonephritis Escherichia coli pili linear immunogenic and antigenic epitopes.
364. The role of Tamm-Horsfall protein in the pathogenesis of reflux nephropathy and chronic pyelonephritis.
365. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis.
366. CT of xanthogranulomatous pyelonephritis: radiologic-pathologic correlation.
367. Experimental pyelonephritis. The effect of T-cell deficiency on the course of hematogenous enterococcal pyelonephritis in the mouse.
368. Frequency of gene sequences necessary for pyelonephritis-associated pili expression among isolates of Enterobacteriaceae from human extraintestinal infections.
369. P-fimbriae, bacterial adhesion, and pyelonephritis.
370. Low urinary counts of P-fimbriated Escherichia coli in presumed acute pyelonephritis.
371. Xanthogranulomatous pyelonephritis (report of 2 cases).
372. Tubulointerstitial inflammation, cast formation, and renal parenchymal damage in experimental pyelonephritis.
373. Effect of indomethacin on the incidence of experimental Escherichia coli pyelonephritis.
374. Identical twins with identical vesicoureteric reflux: chronic pyelonephritis in one.
375. Scarring as a factor affecting the eradication of microorganisms from the kidney in pyelonephritis.
376. Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin.
377. Acute pyelonephritis caused by Staphylococcus xylosus.
378. Renal pseudotumours caused by xanthogranulomatous pyelonephritis.
379. Serological response to Escherichia coli pili in pyelonephritis.
380. Biliary obstruction due to xanthogranulomatous pyelonephritis.
381. Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.
382. Experimental Escherichia coli ascending pyelonephritis in rats: changes in bacterial properties and the immune response to surface antigens.
383. Experimental Candida albicans, Staphylococcus aureus, and Streptococcus faecalis pyelonephritis in diabetic rats.
384. Rifampin, ampicillin, streptomycin, and their combinations in the treatment of enterococcal pyelonephritis in rats.
385. Experimental retrograde pyelonephritis and cystitis induced in rabbits by a group D Streptococcus sp.: serum antibody assay by a hemagglutination test.
386. Intrarenal concentrations of ampicillin in acute pyelonephritis.
387. Prevention of acute and chronic ascending pyelonephritis in rats by aminoglycoside antibiotics accumulated and persistent in kidneys.
388. Hemagglutination of human type O erythrocytes, hemolysin production, and serogrouping of Escherichia coli isolates from patients with acute pyelonephritis, cystitis, and asymptomatic bacteriuria.
389. Local immune response to Escherichia coli pili in experimental pyelonephritis.
390. Study of antibody-coated fungi in patients with funguria and suspected disseminated fungal infections or primary fungal pyelonephritis.
391. Sonographic features of xanthogranulomatous pyelonephritis.
392. Xanthogranulomatous pyelonephritis presenting with unilateral renal vein thrombosis.
393. An experimental model for ascending acute pyelonephritis caused by Escherichia coli or proteus in rats.
394. Gallium-67 radionuclide imaging in acute pyelonephritis.
395. Virulence of Escherichia coli in experimental hematogenous pyelonephritis in mice.
396. Antipili antibody affords protection against experimental ascending pyelonephritis.
397. Diagnosis of Mycoplasma hominis pyelonephritis by demonstration of antibodies in urine.
398. Emphysematous pyelonephritis demonstrated by computed tomography.
399. Ultrasonic characteristics of chronic atrophic pyelonephritis.
400. Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria.
401. Mycoplasmas in human pyelonephritis: demonstration of antibodies in serum and urine.
402. Influence of iron on Corynebacterium renale-induced pyelonephritis in a rat experimental model.
403. Occurrence of mycoplasmas in urinary tracts of patients with acute pyelonephritis.
404. Elevated plasma renin activity in patients with acute pyelonephritis.
405. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
406. Modification by suppressor cells and serum factors of the cell-mediated immune response in experimental pyelonephritis.
407. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration.
408. Experimental Rat model for Corynebacterium renale-induced pyelonephritis.
409. Local immune response to lipoprotein of the outer membrane of Escherichia coli in experimental pyelonephritis.
410. The effects of cobra venom factor, an inhibitor of the complement system, on the sequence of morphological events in the rat kidney in experimental pyelonephritis.
411. Experimental model of corynebacterium renale pyelonephritis produced in mice.
412. Urinary LDH isoenzyme 5 excretion in experimental pyelonephritis.
413. Clinical evaluation of the effect of cefuroxime in patients with pyelonephritis and osteomyelitis.
414. Experimental investigations of cefuroxime in renal tolerance and therapeutic efficacy in pyelonephritis.
415. A study of the intrarenal recycling of urea in the rat with chronic experimental pyelonephritis.
416. The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.
417. Local immunie response in experimental pyelonephritis in the rabbit. III. Lymphocyte responsivieness to O and K antigens of Escherichia coli.
418. Immunological enhancement in the pathogenesis of pyelonephritis.
419. Local immune response in experimental pyelonephritis in the rabbit. II. Lymphocyte stimulation by lipopolysaccharide of infecting organism.
420. Local immune response in experimental pyelonephritis in the rabbit. I. Morphological and functional features of the lymphocytic infiltrate.
421. Pyelonephritis and hypertension.
422. Quantitation of immunoglobulin-bearing lymphocytes and the lymphocyte response to PHA in experimental pyelonephritis.
423. Letter: renal imaging and pyelonephritis.
424. An ultrastructural study of the renal medulla in experimental acute pyelonephritis.
425. Experimental Escherichia coli O6 pyelonephritis in rabbits. Effect on O6 antibody quantity and avidity of prior immunization with E. coli O2 bacteria.
426. The relation between experimentally induced pyelonephritis and hypertension.
427. Host-parasite interaction in the rat renal pelvis: a possible role for pili in the pathogenesis of pyelonephritis.
428. Cinoxacin: effectiveness against experimental pyelonephritis in rats.
429. Local antibody production in experimental pyelonephritis: amount, avidity, and immunoglobulin class.
430. Hematogenous Streptococcus faecalis pyelonephritis in the rat. A histologic, immunopathologic and bacteriologic study.
431. Gallium-67 scans in the diagnosis of pyelonephritis.
432. Pyelonephritis. 18. Effect of treatment on the pathology of enterococcal pyelonephritis in the rat.
433. Emphysematous pyelonephritis.
434. Differential antibiotic excretion in unilateral structural pyelonephritis.
435. The role of the T cell in experimental pyelonephritis.
436. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
437. Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats.
438. Pyelonephritis in pregnancy.
439. An in vivo pyelonephritis assay for screening therapeutic agents.
440. Pyelonephritis XVI. correlates of parasite virulence in acute ascending Escherichia coli pyelonephritis in mice undergoing diuresis.
441. Pyelonephritis XV. Long-term study of ascending Escherichia coli pyelonephritis in mice.
442. Loin percussion in acute pyelonephritis.
443. Experimental pyelonephritis. 18. Pseudomonas aeruginosa and E. coli prostatic infection in the rat and the effects of water diuresis.
444. Influence of water diuresis on antimicrobial treatment of enterococcal pyelonephritis.
445. Pyelonephritis. XIV. Effect of immunization on experimental Escherichia coli pyelonephritis.
446. Xanthogranulomatous pyelonephritis in a tetraplegic patient.
447. Xanthogranulomatous pyelonephritis. A comparison of the disease in the cat and man with special reference to the origin of the fat.
448. Effect of antibacterial therapy on renal lysozyme levels in rats developing bacterial pyelonephritis.
449. Experimental pyelonephritis. XVII. Enhancement of pyelonephritis by water diuresis following direct inoculation of E. coli in the renal medulla of the rat.
450. Antibody synthesis in kidney, spleen and lymph nodes in acute and healed focal pyelonephritis.
451. A diagnostic pattern of nocturnal solute excretion in pyelonephritis.
452. Renal lysozyme levels in animals developing "sterile pyelonephritis".
453. The effect of preliminary sensitization and immunization on bacteriuria in rabbits with experimental pyelonephritis.
454. Bacteremia in the pathogenesis of retrograde E. coli pyelonephritis in the rat.
455. What is chronic pyelonephritis?
456. Characterization of precipitating antibodies to E. coli O antigen in infants and children with acute pyelonephritis.
457. Renal lysozyme levels in animals developing Proteus mirabilis-induced pyelonephritis.
458. Renal scintigraphy in pyelonephritis.
459. Experimental pyelonephritis. XVI. Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus infections in mice and the effect of "water diuresis".
460. Pyelonephritis therapy in rats: random association with excreted urinary antibacterial activity.
461. Prevention of experimental hematogenous and retrograde pyelonephritis by antibodies against enterobacterial common antigen.
462. Urinary concentrating ability in early experimental pyelonephritis.
463. Pyelonephritis XI. Effect of Growth Phase of Streptococcus faecalis on Serum Susceptibility and Virulence.
464. The effect of parenteral iron preparations on experimental pyelonephritis.
465. Pyelonephritis lenta. Consideration of childhood urinary infection as the forerunner of renal insufficiency in later life.
466. Pyelonephritis and associated infections of the urinary tract.
467. Nephrogenic hepatic dysfunction: secondary to tumefactive xanthogranulomatous pyelonephritis.
468. Water, acidosis, and experimental pyelonephritis.
469. Local immune response in experimental pyelonephritis.
470. Xanthogranulomatous pyelonephritis.
471. Rat pyelonephritis model suitable for primary or secondary screening.
472. Experimental pyelonephritis. XV. Increased susceptibility to E. coli infection in old rats.
473. Renal damage after acute pyelonephritis.
474. Significance of bacterial L-form in urinary infections, in particular, the mechanism in causing pyelonephritis.
475. Eleven-year follow-up of a patient with malignant hypertension secondary to pyelonephritis and renal insufficiency.
476. Renal tubular acidosis of pyelonephritis with renal stone disease.
477. Infectious and immune synergistic factors in tissue injury. Parallels between chronic obstructive respiratory disease and chronic pyelonephritis.
478. Comparison of the patterns of pyuria in experimental pyelonephritis caused by Streptococcus faecalis and Pseudomonas aeruginosa.
479. Experimental pyelonephritis in dogs.
480. Serum and urine proteins in pyelonephritis.
481. Evaluation of the antibacterial effect of nalidixic acid in two experimental models of Escherichia coli pyelonephritis.
482. Diagnosis of pyelonephritis in children.
483. Diagnosis of pyelonephritis in children.
484. Experimental pyelonephritis. XIV. Pyelonephritis in normal mice produced by inoculation of E. coli into the bladder lumen during water diuresis.
485. Effects of a behavioral stimulus on blood pressure of rats with experimental pyelonephritis.
486. Single-dose treatment of pyelonephritis.
487. The role of penicillin-induced bacterial variants in experimental pyelonephritis.
488. A study of the renal vascular patterns in hypertension, chronic pyelonephritis and other diseases. Hunterian Lecture delivered at the Royal College of Surgeons of England on 24th February 1966.
489. Experimental pyelonephritis. 13. On the ability of water diuresis to induce susceptibility to E. coli bacteriuria in the normal rat.
490. A case of infectious cystitis and pyelonephritis of swine caused by Corynebacterium suis.
491. Experimental pyelonephritis. XII. Changes mimicking chronic pyelonephritis as a consequence of renal vascular occlusion in the rat.
492. Pyelonephritis in children.
493. Pyelonephritis and reflux.
494. The urethral syndrome and pyelonephritis.
495. Drugs for Recurrent or Persistent Pyelonephritis.
496. Drugs for Recurrent or Persistent Pyelonephritis.
497. Coarse pyelonephritic scarring or 'atrophic pyelonephritis'.
498. Pyelonephritis. Urinary tract infections--localization of the site of infection and its effect upon treatment.
499. TISSUE CONCENTRATION OF NALIDIXIC ACID IN CHRONIC PYELONEPHRITIS.
500. Drugs for Recurrent or Persistent Pyelonephritis.
501. DRUGS FOR RECURRENT OR PERSISTENT PYELONEPHRITIS.
502. PYELONEPHRITIS IN CHILDREN. AN INTERIM REVIEW OF RECENT LITERATURE.
503. THE RADIOLOGY OF CHRONIC PYELONEPHRITIS.
504. DIAGNOSTIC CRITERIA OF PYELONEPHRITIS.
505. Drug Therapy for Acute Pyelonephritis.
506. Drug Therapy for Acute Pyelonephritis.
507. DRUGS FOR RECURRENT OR PERSISTENT PYELONEPHRITIS.
508. DRUGS FOR ACUTE PYELONEPHRITIS.
509. EXPERIMENTAL PYELONEPHRITIS: OBSERVATIONS ON MIXED INFECTION.
510. PREVENTION OF PYELONEPHRITIS BY WATER DIURESIS: EVIDENCE FOR THE ROLE OF MEDULLARY HYPERTONICITY IN PROMOTING RENAL INFECTION.
511. AMPICILLIN IN BACTERIURIA AND PYELONEPHRITIS OF PREGNANCY.
512. PYELONEPHRITIS.
513. INCREASED SUSCEPTIBILITY OF MICE INFECTED WITH MOUSE ADENOVIRUS TO ESCHERICHIA COLI-INDUCED PYELONEPHRITIS.
514. PYELONEPHRITIS IN CHILDHOOD.
515. PATHOGENESIS OF CHRONIC PYELONEPHRITIS. II. EFFECT OF REPETITIVE INFECTION.
516. CLINICOPATHOLOGICAL STUDIES OF CHRONIC PYELONEPHRITIS BY MEANS OF RENAL BIOPSY OF THE PATIENTS WITH INJURIES OF THE SPINAL CORD.
517. B.M.A. Annual Meeting, Manchester: Panel Discussion on Pyelonephritis.
518. Experimental pyelonephritis. Ascending infection of the rat kidney by organisms residing in the urethra.
519. The effect of diethylstilbestrol on the susceptibility of rats to hematogenous pyelonephritis.
520. Pathogenesis of chronic pyelonephritis. Studies of nonobstructive enterococcal pyelonephritis in the rat.
521. Experimental pyelonephritis. Xi. A comparison of temporary occlusion of renal artery and vein on susceptibility of rat kidney to infection.
522. The role of immunity in the pathogenesis of experimental retrograde pyelonephritis.
523. Experimental pyelonephritis. Characteristics of the infection in dogs.
524. Experimental pyelonephritis. X. The direct injection of e. Coli protoplasts into the medulla of the rabbit kidney.
525. Retrograde Proteus pyelonephritis in rats. Bacteriologic, pathologic and fluorescent-antibody studies.
526. Long-term treatment of chronic pyelonephritis in children.
527. Ureteric Reflux and Pyelonephritis.
528. Problems of chronic pyelonephritis.
529. Presentation and diagnosis of chronic pyelonephritis.
530. Endotoxin tolerance. Ii. Its occurrence in patients with pyelonephritis.
531. Endotoxin tolerance. I. Its induction by experimental pyelonephritis.
532. Retrograde Proteus pyelonephritis in rats. Localization of antigen and antibody in treated sterile pyelonephritic kidneys.
533. Increased susceptibility to pyelonephritis during acute hypertension by angiotensin II and norepinephrine.
534. Bacterial pyrogen in diagnosis of pyelonephritis.
535. Localization and fate of Escherichia coli in hematogenous pyelonephritis.
536. Experimental pyelonephritis. The effect of chronic infection on the blood pressure in the rat.
537. The diagnosis of pyelonephritis in childhood: quantitative culture of non-catheter urine specimens.
538. The role of immunity in the pathogenesis of experimental hematogenous pyelonephritis.
539. Chronic Pyelonephritis, Chronic Interstitial Nephritis and Phenacetin Toxicity.
540. Pyelitis, an important factor in the pathogenesis of retrograde pyelonephritis.
541. Experimental pyelonephritis. IX. The bacteriological course and morphological consequences of staphylococcal pyelonephritis in the rat, with consideration of the specificity of the pathological changes observed.
542. Effect of experimental pyelonephritis on the renal concentrating ability of the rat.
543. Consideration of certain host factors in the pathogenesis of pyelonephritis.
544. Pyelonephritis.
545. Pyelonephritis. I. Observations on the course of chronic non-obstructed enterococcal infection in the kidnev of the rat.
546. Subarachnoid haemorrhage in pregnancy with hypertension due to unilateral pyelonephritis.
547. Susceptibility of rats to experimental pyelonephritis during potassium depletion.
548. Experimental pyelonephritis. VIII. The effect of acidifying agents on susceptibility to infection.
549. Susceptibility to experimental pyelonephritis when hormonal hypertension is prevented by hypotensive drugs.
550. Glomerulonephritis and Pyelonephritis.
551. Experimental pyelonephritis: reactivation of the healing lesion by ureteric occlusion.
552. Role of bacterial urease in experimental pyelonephritis.
553. Experimental pyelonephritis. VII. Evidence on the mechanisms by which obstruction of urine flow enhances susceptibility to pyelonephritis.
554. Experimental pyelonephritis. VI. Observations on susceptibility of the rabbit kidney to infection by a virulent strain of Staphylococcus aureus.
555. Susceptibility of rats to experimental pyelonephritis following recovery from potassium depletion.
556. Effects of unilateral nephrectomy and mixed infection on blood pressure of rats with experimental chronic pyelonephritis.
557. Experimental pyelonephritis. V. Susceptibility of rats to hematogenous pyelonephritis following chemical injury of the kidneys.
558. The radiological diagnosis of pyelonephritis.
559. Hematogenous pyelonephritis in rats. IV. Relationship of bacterial species to the pathogenesis and sequelae of chronic pyelonephritis.
560. Experimental pyelonephritis: the effect of renal vein constriction on bacterial localisation and multiplication in the rat kidney.
561. Hematogenous pyelonephritis in rats. III. Relationship of bacterial species to the pathogenesis of acute pyeionephritis.
562. Susceptibility of rats with hormonal hypertension to experimental pyelonephritis.
563. Experimental pyelonephritis: the influence of temporary and permanent ureteric obstruction on the localization of bacteria.
564. Experimental pyelonephritis. IV. Observations on infections resulting from direct inoculation of bacteria in different zones of the kidney.
565. Experimental pyelonephritis. III. The influence of localized injury in different parts of the kidney on susceptibility to bacillary infection.
566. Pyelonephritis and Drugs.
567. Experimental pyelonephritis. II. Effect of partial ureteral obstruction on the course of bacterial infection in the kidney of the rat and the rabbit.
568. Experimental pyelonephritis. I. Effect of ureteral ligation on the course of bacterial infection in the kidney of the rat.
569. A pathological study of five cases of pyelonephritis in the newborn.
570. Clinical recognition of chronic pyelonephritis.
571. Potassium-losing pyelonephritis.
572. The diminutive kidney; congenital hypoplasia and atrophic pyelonephritis.
573. The diagnosis and treatment of acute pyelonephritis in diabetes mellitus.
574. Factors in the pathogenesis of pyelonephritis.
575. Hematogenous pyelonephritis in rats. I. Its pathogenesis when produced by a simple new method.
576. Chronic pyelonephritis in children.
577. Discussion on chronic pyelonephritis.
578. A plea for the longer treatment of chronic pyelonephritis in children.
579. Discussion on pyelonephritis.
580. Ectopic kidney with nephrolithiasis and pyelonephritis.
581. Partially sex-linked cominant inheritance of interstitial pyelonephritis.
582. Acute glomerulonephritis associated with pyelonephritis, bundle branch block and return extrasystoles due to ventricular extrasystoles with retrograde conduction.
583. A study of the diptheroids found in infectious bovine pyelonephritis.
584. A Study of the Diphtheroids Found in Infectious Bovine Pyelonephritis.
585. Pyelonephritis malignant hypertension and ulceration of small intestine in a child.
586. Unilateral Pyelonephritis and Hypertension.
587. Changing Concepts of Pyelonephritis.
588. The Pathogenesis of Chronic Atrophic Pyelonephritis and its Possible Relation to the Production of Hypertension.
589. Pyelonephritis of Pregnancy.
590. Hypertension in a Girl of 12, Associated with Unilateral, Chronic, Atrophic Pyelonephritis; Treated by Nephrectomy.
591. A case of dissecting aneurysm of the thoracic aorta, with haematoma, nephrolithiasis and pyelonephritis.
592. Chronic pyelonephritis and arterial hypertension.
593. Inflammatory Lesions in the Glomeruli in Pyelonephritis in Relation to Hypertension and Renal Insufficiency.
594. Pyelonephritis in infancy and childhood: its bacteriology and pathology.
595. Pyelonephritis with Renal Failure and ultimate Recovery.
596. A contribution to the epidemiology of specific infectious cystitis and pyelonephritis of cows.
597. The organism associated with specific infectious cystitis and pyelonephritis of cows.
598. Specific infectious cystitis and pyelonephritis of cows.
599. Pyelonephritis: a critical review of 100 cases.
600. Pyelitis and Pyelonephritis, Some Observations from the Clinical and Laboratory Findings in.